IL17A and thymoma: Kisand and colleagues reported on a cohort of 162 patients with APECED and described anti-IL-17A, IL-17F and/or IL-22 AAbs in over 90% of cases, and additionally detected high titer IL-17A and IL-22 AAbs in two patients with thymoma and CMC [30].